Showing results (81-90 of 241) with videos related to

Sort By:
Pageof 25
Plos One|April 24, 2014
Replacement of HA-MRSA by CA-MRSA infections at an academic medical center in the midwestern United States, 2004-5 to 2008Michael Z David, Adriana Cadilla, Susan Boyle-Vavra, et al.
American Journal of Diseases of Children (1960)|November 1, 1980
Cutaneous necrosis associated with intravenous nafcillin therapyS J Tilden, J C Craft, R Cano, et al.
JAMA|March 4, 1992
Severe measles in immunocompromised patientsL J Kaplan, R S Daum, M Smaron, et al.
JAMA|July 3, 1996
The effect of epidemic measles on immunization ratesK P Goldstein, T J Philipson, H Joo, et al.
Pediatrics|April 1, 1982
Evaluation of a commercial latex particle agglutination test for rapid diagnosis of Haemophilus influenzae type b infectionR S Daum, G R Siber, J S Kamon, et al.
The Pediatric Infectious Disease Journal|June 3, 1999
Methicillin-resistant and borderline methicillin-resistant asymptomatic Staphylococcus aureus colonization in children without identifiable risk factorsA H Suggs, M C Maranan, S Boyle-Vavra, et al.
Pediatrics|November 1, 1996
Interchangeability of Haemophilus influenzae type b vaccines in the primary series: evaluation of a two-dose mixed regimenK M Bewley, J G Schwab, G A Ballanco, et al.
The Journal of Infectious Diseases|August 27, 2002
Evidence for a continuum of decreased vancomycin susceptibility in unselected Staphylococcus aureus clinical isolatesFarid M Hussain, Susan Boyle-Vavra, Priya B Shete, et al.
Pediatrics|December 3, 2004
On-time immunization rates among children who enter Chicago public schoolsSamuel R Dominguez, J Scott Parrott, Diane S Lauderdale, et al.
Antimicrobial Agents and Chemotherapy|January 20, 2000
Reversion of the glycopeptide resistance phenotype in Staphylococcus aureus clinical isolatesS Boyle-Vavra, S K Berke, J C Lee, et al.
Pageof 25